Search

Your search keyword '"Babu, K Govind"' showing total 10 results
Start Over Author "Babu, K Govind" Journal south asian journal of cancer
10 results on '"Babu, K Govind"'

1. South Asian Declaration—Consensus Guidelines for COVID-19 Vaccination in Cancer Patients

Author

Thirumalairaj, Raja, additional, Parikh, Purvish M., additional, Agarwal, Amit, additional, Singh, Randeep, additional, Krishnamurthy, Arvind, additional, Desai, Sharad S., additional, Maheshwari, Amita, additional, Mehta, Prashant, additional, Ghafur, Abdul, additional, Somashekhar, S. P., additional, Iqbal, Ahamed, additional, Savant, Dhairyasheel N., additional, Hussain, Syed Md Akram, additional, Bhatt, Amit, additional, Wangdi, Tashi, additional, Bajpai, Jyoti, additional, Ranade, Anantbhushan A., additional, Babu, K. Govind, additional, Bapna, Ajay, additional, Biswas, Ghanshyam, additional, Malhotra, Hemant, additional, Krishna, M. Vamshi, additional, Baral, Rajendra Prasad, additional, Vashishtha, Rajesh, additional, Safi, Ahmad Javid, additional, Agarwal, Sharmila, additional, Agarwal, J. P., additional, Rathnam, Krishna Kumar, additional, Mohapatra, P. N., additional, Kumar, Rajeev Vijay, additional, Rajappa, Senthil, additional, Limaye, Sewanti Atul, additional, Vora, Amish, additional, Reddy, Vijay A.P., additional, Parekh, Bhavesh B., additional, and Rath, G. K., additional

Published
2021
Full Text
View/download PDF

3. Clinical profile and treatment outcomes of metastatic neuroendocrine carcinoma: A single institution experience

Author

Lokesh, K. N., additional, Anand, Abhishek, additional, Lakshmaiah, K. C., additional, Babu, K. Govind, additional, Lokanatha, Dasappa, additional, Jacob, Linu Abraham, additional, Suresh Babu, M. C., additional, Rudresha, A.H., additional, Rajeev, L.K., additional, Saldanha, Smitha C., additional, Giri, G.V., additional, Panwar, Dipti, additional, Koppaka, Deepak, additional, and Patidar, Rajesh, additional

Published
2018
Full Text
View/download PDF

4. Lung cancer in India: Current status and promising strategies

Author

Anantbhushan Ranade, S Koyande, N. Ghadyalpatil, Manish Singhal, A Vora, Babu K Govind, Amit Verma, Gouri Shankar Bhattacharyya, Sachin Hingmire, Purvish M. Parikh, Rose Dawn Bharath, and Randeep Singh

Subjects
0301 basic medicine, Cancer Research, medicine.medical_specialty, business.industry, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, lcsh:RC254-282, 03 medical and health sciences, Editorial Commentary, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Medicine, Current (fluid), business, Intensive care medicine, Lung cancer
Published
2016

5. Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India

Author

Babu, K. Govind, additional, Chaudhuri, Tamojit, additional, Lakshmaiah, K. C., additional, Dasappa, Lokanatha, additional, Jacob, Linu Abraham, additional, Suresh Babu, M. C., additional, Rudresha, A. H., additional, Lokesh, K. N., additional, and Rajeev, L. K., additional

Published
2018
Full Text
View/download PDF

10. A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma.

Author

Nanda R, Katke A, Suneetha N, Thejaswini B, Pasha T, Jagannath KP, Giri GV, and Babu KG

Abstract

Introduction: The chemotherapy schedules with cytotoxic dose or weekly regimes are still challenging, weighing the benefits versus toxicities. This prospective randomized study is an attempt to assess the efficacy of two schedules of cisplatin in management of locally advanced HNSCC., Objectives: The objectives of this study was to evaluate tolerance, tumour response and toxicities of concurrent chemoradiation with cisplatin in weekly and three weekly regimes., Methods: Locally advanced oropharyngeal squamous cell carcinoma patients fit for concurrent chemoradiation with cisplatin 40 mg/m2 (weekly) and 100 mg/m2 (3 weekly) were randomized to Arm A and B concurrently with radiotherapy of 70Gy/35frs/7 weeks., Statistical Analysis: Chi-square/ Fisher Exact test has been used to find the significance of study parameters on categorical scale between the groups. The statistical software SPSS 15.0 was used., Results: Between December 2010 and January 2013, 60 patients were enrolled. The median cycles of cisplatin in Arm-A was 5 and 2 in Arm-B. The complete response of 80.9% vs 75% and partial response of 14.3% vs 12.5% was observed in both arms respectively. There was no statistical difference in acute radiation and hematological toxicities between the two groups. With median follow up of 28 months, the 2 and 5 years overall survival was 55% and 58%; 41.6% and 32.3% in arms A and B respectively., Conclusion: In our study of locally advanced oropharyngeal carcinoma treated with radical radiotherapy comparing concurrent chemotherapy with cisplatin weekly vs 3 weekly had no significant difference in overall response, complete response and acute toxicities., Competing Interests: There are no conflicts of interest.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results